Back to Results
First PageMeta Content
Pharmaceuticals policy / Amines / Eli Lilly and Company / Drugs / Cough medicine / Guaifenesin / Prescription medication / Mucokinetics / Methadone / Medicine / Chemistry / Pharmacology


SUBMISSION FOR THE RECLASSIFICATION OF A MEDICINE
Add to Reading List

Document Date: 2014-05-20 20:48:43


Open Document

File Size: 89,50 KB

Share Result on Facebook

Company

Reckitt Benckiser / Reckitt Benckiser (New Zealand) Ltd / /

Country

United States / Canada / Australia / United Kingdom / New Zealand / /

/

Facility

Pharmacy Only / /

/

IndustryTerm

sustained release cough relief product / modified release guaiphenesin product / healthcare system / sustained cough relief product / /

MedicalCondition

sore throat / Coughs / smoker’s cough / proven effective sustained cough / chronic lower respiratory tract diseases / flu / kidney stones / emphysema / bronchitis / chronic obstructive pulmonary disease / chesty coughs / persistent cough / flu viruses / productive cough / runny nose / Stimulant-associated guaifenesin urolithiasis / hypersensitivity / Cough / tiredness / porphyria / sustained release cough / asthma / /

Organization

Medicines Classification Committee / /

Person

Fabian Dwyer / Linda Morris / Lincoln Manor / /

/

Position

Director-General for distribution as general sale medicines / Minister / General Manager / Pharmacist / EXECUTIVE / Director-General for distribution as restricted medicines / General / Director-General / General Sales / /

Product

MUCINEX / MEDICINE Guaiphenesin Modified Release Tablets / /

URL

http /

SocialTag